FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION

Similar documents
FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION

FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION

FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION

FLORIDA MEDICARE PART B LOCAL MEDICAL REVIEW POLICY

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

Denominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320

LCD for Omalizumab (Xolair ) (L29240)

FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION

Local Coverage Determination (LCD) for Cardiac Catheterization (L29090)

SPECT/CT in knee pain

LCD for Interferon (L29202)

Department of Radiology, University of Szeged. Imaging of the skeleton

LCD for Sargramostim (GM-CSF, Leukine ) (L29275)

Local Coverage Determination for Hospice - Liver Disease (L31536)

Austin Radiological Association Nuclear Medicine Procedure BONE MINERAL STUDY (Tc-99m-MDP, Tc-99m-HMDP)

LCD Information Document Information LCD ID Number L30046

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

PROPOSED/DRAFT Local Coverage Determination (LCD): MolDX: Chromosome 1p/19q deletion analysis (DL36483)

THE ADVANTAGES OF bone scintigraphy for patients with

Local Coverage Determination for Hospice The Adult Failure To Thrive Syndrome (L31541)

MolDX: Chromosome 1p/19q deletion analysis

Cardiovascular nuclear imaging employs non-invasive techniques to assess alterations in coronary artery flow, and ventricular function.

POSITRON EMISSION TOMOGRAPHY (PET)

Chealon Miller, HMS IV Gillian Lieberman, MD. November Stress Fractures. Chealon Miller, Harvard Medical School Year IV Gillian Lieberman, MD

Scintillations. spect lab. A group of donkeys led by a lion can defeat a group of lions led by a donkey - Socrates. nuclear medicine services

Local Coverage Determination for Colorectal Cancer Screening (L29796)

Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Jurisdiction Oregon. Retirement Date N/A

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

From 2015/2016 Batch

Contractor Number Oversight Region Region IV

Joint Comments on Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (CAG-00065R1)

Contractor Number 03201

SPECT CT in the Evaluation of Musculoskeletal Disease

Update on Pediatric Bone Scintigraphy

Contractor Information. LCD Information

Jurisdiction Georgia. Retirement Date N/A

Local Coverage Article for Chiropractic Services (A47798) Contractor Information. Article Information. Contractor Name. Contractor Numbers

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Local Coverage Determination (LCD): RAST Type Tests ( L30524 )

LCD L B-type Natriuretic Peptide (BNP) Assays

Local Coverage Determination for Hospice Alzheimer's Disease &Related Disorders (L31539)

INFECTION & INFLAMMATION IMAGING

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR MAGNETIC RESONANCE IMAGING:

Clinical Appropriateness Guidelines: Advanced Imaging

Atlas of Bone Scintigraphy in the Developing Paediatric Skeleton. The Normal Skeleton, Variants and Pitfalls

Complex Fractures and Hip Dislocations

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Epidemiology of Low back pain

Nuclear Medicine in the Diabetic Foot

Musculoskeletal Radiology

Combined SPECT/CT bone scintigraphy; a superior technique for diagnosis of benign and malignant conditions in the spine.

CHAPTER 13 SKELETAL SYSTEM

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR MAGNETIC RESONANCE IMAGING:

SYLLABUS. 2.0 units, 33 hours (3 hours lecture per week)

Not everything that's hot on a bone scan is malignant: A pictorial review of benign causes of increased isotope uptake

Radiology Codes Requiring Authorization*

LCD KYPHOPLASTY. Contractor Information. LCD Information

Coding Companion for Oncology/Hematology. A comprehensive illustrated guide to coding and reimbursement

Chapter 5 Section 1.1. Diagnostic Radiology (Diagnostic Imaging)

Multiple Gated Acquisition (MUGA) Scanning

National Oncologic PET Registry (NOPR) F-18 Fluoride PET Case Report Forms

Wilderness related musculoskeletal injury: role of bone scintigraphy

Nuclear Medicine - Hepatobiliary

Primary bone tumors > metastases from other sites Primary bone tumors widely range -from benign to malignant. Classified according to the normal cell

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

Chapter 3 Diagnostic Imaging. 1 Diagnostic Imaging

Children's (Pediatric) Nuclear Medicine

National Imaging Associates, Inc. Clinical guidelines

Original Date: October 2015 LUMBAR SPINAL FUSION FOR

MRI XR, CT, NM. Principal Modality (2): Case Report # 2. Date accepted: 15 March 2013

H: Orthopedic Nursing

Bone Metastasis. Patient Management with PET/CT

OSTEOMYELITIS. If it occurs in adults, then the axial skeleton is the usual site.

b. To facilitate the management decision of a patient with an equivocal stress test.

Jurisdiction New Mexico. Retirement Date N/A

Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Jurisdiction Oregon. Retirement Date N/A

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Local Coverage Determination (LCD) for Endoscopic Treatment of GERD (L28256)

Jurisdiction Nebraska. Retirement Date N/A

APMA 2018 Radiology Track Bone Tumors When to say Gulp!

12102, 12202, 12302, 12501, 12301, 12201, 12401, 12402, 12101, 12502, 12901

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR MAGNETIC RESONANCE IMAGING:

Palliative treatment of bone metastases with samarium-153

Original Date: April 2016 Page 1 of 7 FOR CMS (MEDICARE) MEMBERS ONLY

Heterogeneous osteoblastic activity in the right ischium of unclear etiology seen on NaF18-PET/CT

12/13/17. Policy Number: MCR: 627 Revision Date(s): 12/11/18. Review Date: 12/13/17, 12/19/18 DISCLAIMER

Institution INSTRUCTIONS (I6) 1. This form is to be completed by a DESIGNATED STUDY NUCLEAR MEDICINE SPECIALIST

MRI of Pediatric Ankle and Foot. Mahesh Thapa, MD Associate Professor Seattle Children s University of Washington School of Medicine

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

Whole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review

2015 Reimbursement Information for Mammography, CAD and Digital Breast Tomosynthesis 1

AIM 2014 CPT Radiology & Cardiac Codes Requiring Review

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Clinical Appropriateness Guidelines: Advanced Imaging

Dr Alfred O Ankrah FCNP

Brain Tumors. What is a brain tumor?

Hybrid bone scintigraphy in gastrointestinal malignancies Institutional Experience

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

04/03/2013. Second Annual BIR SPECT/CT Symposium London, UK 25/02/2013. NMD: Al-Jahra Hospital. NMD: Al-Jahra Hospital

Nuclear pulmonology. Katalin Zámbó Department of Nuclear Medicine

Transcription:

FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION CPT/HCPCS Codes 78300 Bone and/or joint imaging; limited area 78305 multiple areas 78306 whole body 78315 three phase study 78320 tomographic (SPECT) LCD Number 78300 LCD Database ID Number L13841 Contractor Name First Coast Service Options, Inc. Contractor Number 00590 Contractor Type Carrier LCD Title Bone and/or Joint Imaging AMA CPT Copyright Statement CPT codes, descriptions, and other data only are copyright 2004 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. CMS National Coverage Policy Primary Geographic Jurisdiction

Florida Secondary Geographic Jurisdiction CMS Region Region IV CMS Consortium Southern Original Determination Effective Date 06/30/2003 Original Determination Ending Date Revision Effective Date 09/13/2005 Revision Ending Date 09/12/2005 Indications and Limitations of Coverage and/or Medical Necessity Bone and/or joint imaging, also known as a bone scan, skeletal scintigraphy, or a radionuclide bone scan is a nuclear medicine study utilizing an intravenous injection of a technetium-99m phosphonate radiopharmaceutical which localizes in bone with intensity proportional to the degree of metabolic activity present. This diagnostic study records the distribution of this radioactive tracer in the skeletal system in planar (two-dimensional) and/or tomographic (three-dimensional) images normally 2-4 hours after the injection of the radiopharmaceutical agent. A whole body bone scan produces planar images of the skeleton including anterior and posterior views of the axial skeleton. Anterior and/or posterior views of the appendicular skeleton are also obtained. Additional views may be obtained as needed. The limited bone scan records images of only a portion of the skeleton. Bone single photon emission computed tomography (SPECT) produces a tomographic image of a portion of the skeleton. This technique increases diagnostic accuracy by improving sensitivity, providing more precise localization of the radiopharmaceutical, and allowing improved visualization of subtle abnormalities. Three-phase imaging, also known as multiphase bone scintigraphy consists of blood flow images, immediate images and delayed images and is utilized to distinguish skeletal from soft-tissue infection. The blood flow images consist of a dynamic sequence of planar images of the area of greatest interest obtained

as the tracer is injected. The immediate (blood pool) images consist of one or more static planar images of the areas of interest, obtained within 10 minutes after injection of the tracer. Delayed images may be limited to the areas of interest or may include the whole body, may be planar or tomographic, and are usually acquired 2 to 5 hours after injection. Further additional images obtained up to 24 hours following the tracer injection may be obtained if necessary. Florida Medicare will consider bone and/or joint imaging medically reasonable and necessary for the following indications: Extraskeletal primary malignancies for the presence of metastatic disease. The application of imaging in these patients include initial staging, protocol monitoring in response to chemotherapy and decision to change therapy, radiation therapy for treatment field planning and response to radiation therapy, and detection of areas at risk for pathological fracture. Primary malignant bone tumors when metastasis is suspected. Normally, plain radiographs, CT and MRI are a better diagnostic test to portray the tumor margins in bone and allow assessment of soft tissue extent. However, a whole body scan is appropriate to assess osseous metastasis. Benign bone tumors including osteoid osteomas, osteochondromas, chondroblastomas and enchondromas. Skeletal trauma to evaluate the presence of occult fractures when the initial standard radiographic procedure is normal and the clinical presentation is highly suspicious of fracture. Assessing the full extent of injury in patients with multiple injuries. Athletic injuries to evaluate for stress fractures and shin splints. Determine bone viability in infarction, osteonecrosis, and grafts. Osteomyelitis. The evaluation of osteomyelitis is performed utilizing the triple-phase bone scan. This technique is used to differentiate osteomyelitis from cellulitis. Diagnosis and evaluation of musculoskeletal infections to rule out bone involvement. A triple-phase bone scan is utilized for this indication. Metabolic bone disease such as osteoporosis and Paget s Disease when the results of the bone scan will be used to guide treatment. Diagnosis and evaluation of reflex sympathetic dystrophy. The evaluation of reflex sympathetic dystrophy is performed utilizing the triple-phase bone scan. Evaluate a prosthetic joint for loosening or infection. Unexplained musculoskeletal pain when the initial standard radiographic procedure fails to determine the etiology and a musculoskeletal etiology is suspected. Evaluation of abnormal radiographic findings or abnormal laboratory findings demonstrating skeletal involvement. Determine the distribution of osteoblastic activity prior to therapy with strontium-89.

Note: as indicated above, the triple-phase bone scan is normally utilized to evaluate, but not limited to: trauma, neoplasm, and osteomyelitis; diagnose and evaluate musculoskeletal infections to rule out bone involvement; and to diagnose and evaluate reflex sympathetic dystrophy. Therefore, it is expected that this technique is utilized to evaluate these conditions. Skeletal scintigraphy is a sensitive marker of both osteoarthritis and rheumatoid arthritis. Numerous attempts have been made over the last two decades to develop scintigraphic techniques for staging the severity of arthritis and assessing response to therapy. These have been largely unsuccessful, and skeletal scintigraphy, although not common, may be used to evaluate arthritis in current clinical practice. It is expected that a whole body scan (procedure code 78306) is performed only when an evaluation of the entire skeletal system is necessary, such as the evaluation for metastatic disease, or for the evaluation of localized pain of unknown etiology. A limited or muliple area body scan is medically necessary when the patient s signs, symptoms, or condition is limited to a certain body area. For example, it is expected that a limited bone scan be performed on patients with a stress fracture of the foot. A multiple area body scan is necessary in conditions in which more than one body area is affected, however, a total assessment of the skeletal system is not needed. A triple-phase body scan is medically necessary for the assessment of the skeletal system to differentiate a skeletal infection versus a soft tissue infection. Coverage Topic Diagnostic Tests and X-Rays CPT/HCPCS Codes 78300 Bone and/or joint imaging; limited area 78305 multiple areas 78306 whole body 78315 three phase study 78320 tomographic (SPECT) ICD-9 Codes that Support Medical Necessity Diagnoses that Support Medical Necessity ICD-9 Codes that DO NOT Support Medical Necessity Diagnoses that DO NOT Support Medical Necessity Documentation Requirements

Medical record documentation must clearly indicate the medical necessity of the service being billed. In addition, the documentation must support that the service was performed. This information is normally found in the office/progress notes, hospital records, and test results. If the provider of the service is other than the ordering/referring provider, the provider of the service must maintain documentation of the test results and interpretation, along with copies of the ordering/referring provider s order for the studies. The ordering/referring provider must state the reason for the study in the order for the test. Utilization Guidelines It is expected that these services would be performed as indicated by current medical literature and/or standards of practice. When services are performed in excess of established parameters, they may be subject to review for medical necessity. Sources of Information and Basis for Decision Greenspan, A., & Tehranzadeh, J. (2001). Imaging of musculoskeletal and spinal infections: Imaging of infectious arthritis. Radiologic Clinics of North America, 39(2). Retrieved October 14, 2002 from MD Consult database on the World Wide Web: http://home.mdconsult.com. Used to support the use of bone scans for musculoskeletal infections. Michota, F. A. (2001). Diagnostic Procedures Handbook (2 nd ed.). Cleveland, OH: Lexi-Comp Inc. Used to support the indications for coverage. Noble, J. (2001). Textbook of primary care medicine (3 rd ed.). St Louis: Mosby, Inc. Supported the use of a triple-phase bone scan for reflex sympathetic dystrophy. Society of Nuclear Medicine (2003). Procedure Guideline for Bone Scintigraphy. Retrieved from http://interactive.snm.org/index.cfm on August 26, 2005. The American College of Radiology (2002). ACR standard for the performance of adult and pediatric skeletal scintigraphy. Retrieved from http://www.acr.org/s_acr/sec.asp on August 26, 2005. Thrall, J. H., & Ziessman, H. A. (2001). Nuclear medicine: The requisites (2 nd ed.). St Louis: Mosby. Supported the indications identified in the policy. Advisory Committee Notes This policy does not reflect the sole opinion of the contractor or Contractor Medical Director. Although the final decision rests with the contractor, this policy was developed in cooperation with advisory groups, which includes representatives from numerous societies. Carrier Advisory Committee Meeting held on 12/07/2002. Start Date of Comment Period End Date of Comment Period

Start Date of Notice Period Revision History Revision Number: Start Date of Comment Period: Start Date of Notice Period: Revised Effective Date: 1 09/13/2005 LCR B2005-084 Explanation of Revision: Policy converted into LCD format. References were updated with current medical literature. Revision Number Start Date of Comment Period: Start Date of Notice Period: Original Effective Date Original 11/29/2002 05/01/2003 06/30/2003 PCR B2003-126 3 rd Quarter 2003 Update Related Documents LCD Attachments Document formatted: 08/30/2005 (SH/st)